OR WAIT null SECS
July 21, 2021
Pall has secured a manufacturing contract with Exothera for the suspension-based manufacture of gene therapies and viral vector-based vaccines.
July 16, 2021
The new lab near Continuus Pharmaceutical’s current facilities in Massachusetts will expand the company’s process development capabilities to high-potency drugs.
July 15, 2021
Aptamer Group has signed a contract with a global pharmaceutical company to use Optimers to support innovative vaccine development for neurodegenerative disease.
CDMO Idifarma has launched a new service aimed at delivering an accelerated pathway for complex drugs.
July 13, 2021
GEA’s plug-and-produce skids are designed for multi-product pharmaceutical and biopharmaceutical separation.
NewAge Industries is adding cleanrooms at its Pennsylvania headquarters.
July 12, 2021
Purisys is now certified for ISO 17025 for testing and calibration laboratories and ISO 17034 for reference material producers
July 08, 2021
A new media panel, gene kit, and advanced resins that are now in Thermo Fisher Scientific’s gene therapy portfolio aim to reduce manufacturing costs and increase gene therapy viability.
Exscientia has been given funding from the COVID-19 Therapeutics Accelerator to accelerate the optimization of a new class of COVID-19 drugs created using its AI drug design platform.
V. Ashok has been appointed as ACG's new group chief financial officer.